Company Profile & Stock Brokers’ Analysis
It is our company’s policy not to endorse or vet independent brokers’/analysts’ reports written about SomnoMed Limited. When we become aware of a professional report written about our company, we will list the title and brokers’/analysts’ contact details for further reference on SomnoMed’s website
Date Title of Report Issuer Contact Contact Details
02/ 02 / 2010 SomnoMed Limited Hanuman Tony Gordon Hanuman Private Wealth
tony.gordon@hanumans.com.au
www.hanumans.com.au
30 / 07 / 2008 SomnoMed Limited Baillieu Andrew McHarg E.L. &C. Stockbroking Ltd
ABN 74 006 519 393
www.baillieu.com.au
SomnoMed ASX Announcements
For a complete list of all ASX Announcements visit SomnoMed Company Information on ASX
27 January 2010 - SomnoMed accelerates Growth beyond forecasts
31 December 2009 - 4C Quaterly Report
18 January 2010 - SomnoMed Launches New Product Line to Treat Sleep Bruxism
27 November 2009 - Annual General Meeting Results 2009
30 October 2009 - 4C Quaterly Report
26 October 2009 - SomnoMed now profitable
6 October 2009 - SomnoMed welcomes ResMed’s entry into the oral appliance market
20 August 2009 - Investors presentation
30 June 2009 - Preliminary Final Report 2009
17 June 2009 - SLEEP 2009 - Seattle SomnoMed is the leading company in Dental Sleep Medicine
27 April 2009 - Investors Presentation
27 April 2009 - March 09 update
31 March 2009 - Appendix 4C quaterly report
16 February 2009 - SomnoMed enters Japan
31 December 2008 - Appendix 4D and Half-Year Financial Report 31 December 2008
22 December 2008 - Change of Director's interest notice
7 September 2008 - Granted European patent
27 October 2008 - Growth continues unabated
27 October 2008 - Quaterly cash flow
15 October 2008 - New issue announcement
11 September 2008 - SomnoMed Investor Presentation 2008
28 August 2008 - ASX Preliminary final report – 30 June 2008
28 July 2008 - SomnoMed USA subsidiary achieves fourth quarter profitability
28 July 2008 - Quarterly report for entities admitted on the basis of commitments
10 June 2008 - Investor Update
30 April 2008 - Quarterly Report
30 April 2008 - SomnoMed accelerates third quarter global unit sales
19 March 2008 - SomnoMed Appoints Four Distribution Partners in Europe
18 March 2008 - Change of Director’s Interest Notice
17 March 2008 - SomnoMed to Benefit from US Medicare decision
25 February 2008 - SomnoMed Half Year Financial Report
25 February 2008 - SomnoMed Unit Sales up 56% – strongest growth in US
1 January 2008 - SomnoMed Receives FDA Approval for New SMH Biomaterial
18 December 2007 - SomnoMed signs License Agreement for the USA
12 November 2007 - SomnoMed Appoints Head for European Operation
31 October 2007 - SomnoMed First Quarter up 34% Due to Jump in US Sales
5 October 2007 - Share Placement and Share Purchase Plan
30 August 2007 - ASX Preliminary Final Report 30 June 07
1 August 2007 - SomnoMed Acquires interest in Swiss Bio Plastic Venture
11 July 2007 - New SomnoMed CEO Appointment
5 June 2007 - SomnoMed European Expansion
SomnoMed Annual Reports
SomnoMed Annual Report 2009
SomnoMed Annual Report 2008
SomnoMed Annual Report 2007
SomnoMed Annual Report 2006
SomnoMed Annual Report 2005
SomnoMed Annual Report 2004